Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

< Back to Article

Table 1.

Characteristics of patients, derivation and validation cohorts.

There was no significant difference between the two groups (p>0.05).

More »

Table 1 Expand

Table 2.

Distribution of the AKI stages in the derivation and validation cohorts.

There was no significant difference between the two groups (p>0.05).

More »

Table 2 Expand

Table 3.

Predictors of AKI in derivation cohorts (n = 455).

More »

Table 3 Expand

Table 4.

AKI risk score of the final model.

More »

Table 4 Expand

Fig 1.

Distribution of AKI by AKI risk score levels—Derivation cohort (n = 455).

More »

Fig 1 Expand

Fig 2.

Distribution of AKI by AKI risk score levels—Validation cohort (n = 237).

More »

Fig 2 Expand